secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMMUNIC, INC. (IMUX)
CIK:        0001280776
Form:       8-K
Filed at:   2025-04-09T23:59:59+00:00
Accession:  0001193805-25-000454
Event type: other
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immunic prices $5.1M registered direct offering of 5.67M shares at $0.90/share
------------------------------------------------------------------------------

- Offering led by Aberdeen Investments; Titan Partners as placement agent.
- Gross proceeds ~$5.1M; net proceeds ~$4.6M after commissions and expenses.
- Shares sold at $0.90 per share under existing shelf registration statement.
- Expected to close on April 10, 2025; proceeds to fund clinical trials and operations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1280776/000119380525000454/0001193805-25-000454-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1280776/000119380525000454/e664373_8k-immunic.htm
  HTML page:      https://secwatch.observer/filing/0001193805-25-000454

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer